CompletedNCT06657469
Official study titleEffects of Computerized Progressive Attention Training Vs. Executive Functions Training in Children with ADHD
This study has finished and is no longer accepting participants.
In Tel AvivADHDInterventional studyAges 8–12
- Countries
- Israel
- Sponsor
- Tel Aviv University
CompletedNCT01993108
Official study titleControl of Cognition: Naltrexone, Methylphenidate, and ADHD Study
This study has finished and is no longer accepting participants.
In Ann ArborADHDMedication studyAges 18–35
- Countries
- United States
- Sponsor
- University of Michigan
CompletedNCT01986062
What is this study about?This study evaluated the effectiveness of AR11 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including BradentonADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Arbor Pharmaceuticals, Inc.
CompletedNCT03375021
Official study titleA Randomized, Double-Blind, Tw0-Period Crossover Study to Assess the Efficacy and Safety of the Ampakine® Compound, CX717, Versus Placebo in Adults With Attention-Deficit Hyperactive Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 18–50
- Countries
- Sponsor
- RespireRx
CompletedNCT02195167
Official study titleA Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT04025814
Official study titleA Digital Health Solution for Improving Parent Adherence to Behavioral Treatment for ADHD
This study has finished and is no longer accepting participants.
In San FranciscoADHDDevice studyAges 6–85
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT05435651
Official study titleA Randomized Clinical Trial to Assess The Effectiveness and Safety of Digital Therapy for Treating Attention Deficit Hyperactivity Disorder in Children
This study has finished and is no longer accepting participants.
In ShanghaiADHDBehavioural studyAges 6–12
- Countries
- China
- Sponsor
- Children's Hospital of Fudan University
CompletedNCT00631280
Official study titleResponse Variability in Children With ADHD
This study has finished and is no longer accepting participants.
In CincinnatiADHDBehavioural studyAges 7–11
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT06530758
Official study titleDoes the Format of the Adult ADHD Self-Report Scale Impact the Results: a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In EdmontonADHDInterventional studyAges 19–65
- Countries
- Canada
- Sponsor
- University of Alberta
CompletedNCT00500071
What is this study about?Researchers studied Vyvanse (lisdexamfetamine dimesylate) to find out how it affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Shire
CompletedNCT02251743
Official study titleDouble-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including AshevilleADHDDevice studyAges 7–10
- Countries
- United States
- Sponsor
- Ohio State University
WithdrawnNCT00562055
What is this study about?This study evaluates the safety and effectiveness of Atomoxetine for people with ADHD.
This study was withdrawn before enrollment.
Location not clearly listedADHDMedication studyAges 18–55
- Countries
- Sponsor
- Pfizer